IDEXX Laboratories Inc (NASDAQ: IDXX) has reported E.P.S. of $2.64 for its fourth fiscal quarter (ending December 31) versus $2.34 for the same period a year ago — an increase of 13%. For the latest four quarters through December 31, E.P.S. were $10.77 versus $10.17 for the same period a year ago — an increase of 6%.
Recent Price Action
IDEXX Laboratories Inc (NASDAQ: IDXX) stock closed at $469.04 on 2/3/25 after a major increase of 11.1%. Moreover, this advance was accompanied by exceptionally high trading volume at 235% of normal. The stock has risen 7.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
IDEXX Laboratories has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. IDEXX Laboratories has a slightly negative Appreciation Score of 33 and a poor Power Rating of 25, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment